[1]
Sava, M., Sommer, G., Daikeler, T., Woischnig, A.-K., Martinez, A.E., Leuzinger, K., Hirsch, H.H., Erlanger, T.E., Wiencierz, A., Bassetti, S., Tamm, M., Tschudin-Sutter, S., Stoeckle, M., Pargger, H., Siegemund, M., Boss, R., Zimmer, G., Vu, D.-L., Kaiser, L., Dell-Kuster, S., Weisser, M., Battegay, M., Hostettler, K.E. and Khanna, N. 2021. Ninety-day outcome of patients with severe COVID-19 treated with tocilizumab – a single centre cohort study. Swiss Medical Weekly. 151, 3132 (Aug. 2021), w20550. DOI:https://doi.org/10.4414/smw.2021.20550.